{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:00:52Z","timestamp":1778886052986,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejphar.2013.10.062","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T13:16:12Z","timestamp":1383830172000},"page":"419-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease"],"prefix":"10.1016","volume":"723","author":[{"given":"Robert E.","family":"Molokie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana J.","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriett","family":"Wittert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie L.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaijie J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.10.062_bib1","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1523\/JNEUROSCI.23-10-04315.2003","article-title":"Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo\/nocebo responses","volume":"23","author":"Benedetti","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.062_bib2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2013.10.062_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.109.152165","article-title":"Acute inhibition of Ca2+\/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice","volume":"330","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.062_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1523\/JNEUROSCI.4346-09.2010","article-title":"Ca2+\/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia","volume":"30","author":"Chen","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.062_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the Extrapyramidal Symptom Rating Scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2013.10.062_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1054\/jpai.2002.128064","article-title":"Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports","volume":"3","author":"Dampier","year":"2002","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2013.10.062_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00043426-200211000-00008","article-title":"Home management of pain in sickle cell disease: a daily diary study in children and adolescents","volume":"24","author":"Dampier","year":"2002","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2013.10.062_bib8","unstructured":"Ezenwa, M.O., Molokie, R.E., Wang, Z.J., Yao, Y., Suarez, M.L., Pullum, C., Fillingim, R.B., Wilkie, D.J., Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic pain (in review)."},{"key":"10.1016\/j.ejphar.2013.10.062_bib9","doi-asserted-by":"crossref","first-page":"e16633","DOI":"10.1371\/journal.pone.0016633","article-title":"Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials","volume":"6","author":"Ferte","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2013.10.062_bib10","doi-asserted-by":"crossref","first-page":"e1606","DOI":"10.1371\/journal.pone.0001606","article-title":"Ca2+\/calmodulin-dependent kinase kinase alpha is expressed by monocytic cells and regulates the activation profile","volume":"3","author":"Guest","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2013.10.062_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0002-9343(66)90038-6","article-title":"Hemoglobinopathic dysfunction of the red cell","volume":"41","author":"Heller","year":"1966","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2013.10.062_bib12","series-title":"Pain Assessment and Management","first-page":"33","article-title":"Visual analogue scales","author":"Huskisson","year":"1983"},{"key":"10.1016\/j.ejphar.2013.10.062_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0304-3959(02)00178-1","article-title":"Comparative study of electronic vs. paper VAS ratings: a randomized, crossover trial using healthy volunteers","volume":"99","author":"Jamison","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2013.10.062_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","article-title":"Chemical structure of phenothiazines and their biological activity","volume":"64","author":"Jaszczyszyn","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2013.10.062_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(81)90199-8","article-title":"Measurement of pain: patient preference does not confound pain measurement","volume":"10","author":"Kremer","year":"1981","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2013.10.062_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(81)90142-1","article-title":"Pain measurement: construct validity of the affective dimension of the McGill Pain Questionnaire with chronic benign pain patients","volume":"11","author":"Kremer","year":"1981","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2013.10.062_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2013.10.062_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.107.132167","article-title":"Reversal of chronic inflammatory pain by acute inhibition of Ca2+\/calmodulin-dependent protein kinase II","volume":"325","author":"Luo","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.062_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.1969.tb00391.x","article-title":"A double-blind trial of a phenothiazine compound in the treatment of clinical crisis of sickle cell anaemia","volume":"16","author":"Mahmood","year":"1969","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2013.10.062_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1744-6155.2001.tb00240.x","article-title":"Childrens' and adolescents' use of diaries for sickle cell pain","volume":"6","author":"Maikler","year":"2001","journal-title":"J. Soc. Pediatr. Nurs."},{"key":"10.1016\/j.ejphar.2013.10.062_bib21","doi-asserted-by":"crossref","unstructured":"Marques, L.O., Lima, M.S., Soares, B.G., 2004. Trifluoperazine for Schizophrenia. Cochrane Database Syst. Rev., CD003545.","DOI":"10.1002\/14651858.CD003545.pub2"},{"key":"10.1016\/j.ejphar.2013.10.062_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.mehy.2011.06.018","article-title":"Presence of neuropathic pain as an underlying mechanism for pain associated with cold weather in patients with sickle cell disease","volume":"77","author":"Molokie","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2013.10.062_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drudis.2011.01.001","article-title":"Phenothiazine: the seven lives of pharmacology's first lead structure","volume":"16","author":"Ohlow","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2013.10.062_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2013.10.062_bib25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.10.062_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.10.062_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0035-9203(68)90035-7","article-title":"A commentary on the anti-sickling effect of the phenothiazine drugs","volume":"62","author":"Raper","year":"1968","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejphar.2013.10.062_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ard.38.6.560","article-title":"Vertical or horizontal visual analogue scales","volume":"38","author":"Scott","year":"1979","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2013.10.062_bib29","series-title":"The Clinical Features of Sickle Cell Disease","first-page":"137","article-title":"The painful crisis","author":"Serjeant","year":"1974"},{"key":"10.1016\/j.ejphar.2013.10.062_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3959(94)00164-A","article-title":"Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance","volume":"61","author":"Shapiro","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2013.10.062_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2013.10.062_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2010.08.045","article-title":"Multiple non-psychiatric effects of phenothiazines: a review","volume":"648","author":"Sudeshna","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.062_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.11.050","article-title":"Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance","volume":"397","author":"Tang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2013.10.062_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2013.10.062_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/asheducation-2010.1.403","article-title":"Neurobiological mechanisms of pain in sickle cell disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Hematol Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.ejphar.2013.10.062_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0742-969X.1990.11882662","article-title":"Cancer pain intensity measurement: concurrent validity of three tools\u2014finger dynamometer, pain intensity number scale, visual analogue scale","volume":"6","author":"Wilkie","year":"1990","journal-title":"Hospice J."},{"key":"10.1016\/j.ejphar.2013.10.062_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0885-3924(02)00638-3","article-title":"Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain","volume":"25","author":"Wilkie","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.ejphar.2013.10.062_bib38","first-page":"18","article-title":"Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease","volume":"102","author":"Wilkie","year":"2010","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.ejphar.2013.10.062_bib39","doi-asserted-by":"crossref","first-page":"a011692","DOI":"10.1101\/cshperspect.a011692","article-title":"World distribution, population genetics, and health burden of the hemoglobinopathies","volume":"2","author":"Williams","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2013.10.062_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/306686a0","article-title":"Evidence for a central component of post-injury pain hypersensitivity","volume":"306","author":"Woolf","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.10.062_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1124\/jpet.110.175539","article-title":"Haloperidol disrupts opioid-antinociceptive tolerance and physical dependence","volume":"338","author":"Yang","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913008406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913008406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:19:29Z","timestamp":1757974769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913008406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":41,"alternative-id":["S0014299913008406"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.062","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}